Testing effectiveness (Phase 2)Study completedNCT01383850
What this trial is testing
NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)
Who this might be right for
Respiratory Distress SyndromeBronchopulmonary Dysplasia
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 51